0001209191-19-023521.txt : 20190403 0001209191-19-023521.hdr.sgml : 20190403 20190403194212 ACCESSION NUMBER: 0001209191-19-023521 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190403 DATE AS OF CHANGE: 20190403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Currie Mark G CENTRAL INDEX KEY: 0001478244 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38787 FILM NUMBER: 19730820 MAIL ADDRESS: STREET 1: C/O CYCLERION THERAPEUTICS, INC. STREET 2: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc. CENTRAL INDEX KEY: 0001755237 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831895370 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-01 0 0001755237 Cyclerion Therapeutics, Inc. CYCN 0001478244 Currie Mark G C/O CYCLERION THERAPEUTICS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 President Common Stock 2019-04-01 4 A 0 51648 0.00 A 51648 D Common Stock 2019-04-02 4 P 0 270107 14.81 A 321755 D Employee Stock Option (Right to Buy) 12.39 2019-04-01 4 A 0 888 0.00 A 2020-02-02 Common Stock 888 888 D Employee Stock Option (Right to Buy) 12.23 2019-04-01 4 A 0 37286 0.00 A 2021-02-01 Common Stock 37286 37286 D Employee Stock Option (Right to Buy) 16.21 2019-04-01 4 A 0 17491 0.00 A 2022-02-01 Common Stock 17491 17491 D Employee Stock Option (Right to Buy) 14.40 2019-04-01 4 A 0 27773 0.00 A 2023-02-01 Common Stock 27773 27773 D Employee Stock Option (Right to Buy) 15.54 2019-04-01 4 A 0 9930 0.00 A 2024-03-03 Common Stock 9930 9930 D Employee Stock Option (Right to Buy) 17.20 2019-04-01 4 A 0 13125 0.00 A 2025-03-16 Common Stock 13125 13125 D Employee Stock Option (Right to Buy) 17.20 2019-04-01 4 A 0 2500 0.00 A 2025-03-16 Common Stock 2500 2500 D Employee Stock Option (Right to Buy) 11.28 2019-04-01 4 A 0 50801 0.00 A 2026-03-01 Common Stock 50801 50801 D Employee Stock Option (Right to Buy) 18.46 2019-04-01 4 A 0 113430 0.00 A 2027-02-27 Common Stock 113430 113430 D Employee Stock Option (Right to Buy) 16.02 2019-04-01 4 A 0 141007 0.00 A 2028-02-21 Common Stock 141007 141007 D Employee Stock Option (Right to Buy) 14.20 2019-04-01 4 A 0 514786 0.00 A 2029-01-29 Common Stock 514786 514786 D In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the Separation. Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation. This option, granted as an annual performance award, is presently exercisable in full. This option to purchase 25,212 shares vests in equal installments upon achievement of certain regulatory and commercial milestones. The option has vested as to 2,500 shares as of the date hereof. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2016. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2017. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2018. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2019. /s/ Larry Miller, Attorney-in-Fact 2019-04-03